25-NHL-45-CC (CA0731003): A Phase 3, Multicenter, Randomized, Open Label Study to Compare the Efficacy and Safety of Golcadomide in Combination with Rituximab (Golca + R) Vs Investigator s Choice in Participants with Relapsed/Refractory Follicular Lymphom